Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3156 participants.
Also called NCT07252544
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 3,156 participants
- Registry
-
NCT07252544
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07252544. Randomized; quadruple masking; primary purpose treatment. Start 2025-12-01 (anticipated); primary completion 2027-08-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)
- Condition
- Stroke, Lacunar
- Condition
- Stroke, Acute Ischemic
- Condition
- Cerebral Small Vessel Diseases
- Intervention (Drug)
- Isosorbide Mononitrate
- Intervention (Drug)
- Butylphthalide
- Intervention (Drug)
- Isosorbide Mononitrate Placebo
- Intervention (Drug)
- Butylphthalide Placebo
- Lead sponsor
- Beijing Tiantan Hospital
- Collaborator
- Shenzhen Second People's Hospital
Record details
- Record id
cardio:ct-nct07252544- Content hash
95d06380a885826c526f8ea2c155c16bfb35345ab81397822df8cb6bedba9ff8